Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia

The clinically ideal time point and optimal approach for the assessment of measurable residual disease (MRD) in patients with acute myeloid leukemia (AML) are still inconclusive. We investigated the clinical value of multiparameter flow cytometry-based MRD (MFC MRD) after induction (n = 492) and two...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Liu, Fu-Jia, Cheng, Wen-Yan, Lin, Xiao-Jing, Wang, Shi-Yang, Jiang, Tian-Yi, Ma, Ting-Ting, Zhu, Yong-Mei, Shen, Yang
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8173083/
https://ncbi.nlm.nih.gov/pubmed/34094982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.677833
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires